Revision history of "Biology of systems in characterising the response to biological drugs in the treatment of inflammatory bowel disease" (Q3158316)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 October 2024

  • curprev 09:4509:45, 10 October 2024DG Regio talk contribs 72,041 bytes +2 Changed label, description and/or aliases in pt
  • curprev 09:4509:45, 10 October 2024DG Regio talk contribs 72,039 bytes +4 Set a claim value: summary (P836): A doença inflamatória intestinal é um problema de saúde pública significativo devido à sua incidência crescente, ao seu aparecimento nas primeiras décadas de vida e à sua condição crónica e, por vezes, invalidante. A chave para o tratamento da doença moderada a grave são os anticorpos monoclonais anti-TNF. No entanto, um terço dos doentes não responde ao tratamento e, dos que o fazem, pelo menos outro terço perderá a sua resposta no primeiro ano de...

22 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 08:5908:59, 4 August 2022DG Regio talk contribs 70,763 bytes +48,322 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 16:2816:28, 12 October 2021DG Regio talk contribs 12,383 bytes +2,188 Created claim: summary (P836): Inflammatory bowel disease is a significant public health problem due to its increasing incidence, appearance in the first decades of life, and chronic and sometimes invalidating condition. The key to the treatment of moderate to severe disease is anti-TNF monoclonal antibodies. However, one third of patients do not respond to treatment, and of those who do so at least another third will lose their response in the first year of treatment. It is...
  • curprev 16:2816:28, 12 October 2021DG Regio talk contribs 10,195 bytes −2,188 Removed claim: summary (P836): Inflammatory bowel disease is a significant public health problem due to its increasing incidence, appearance in the first decades of life, and chronic and sometimes invalidating condition. The key to the treatment of moderate to severe disease is anti-TNF monoclonal antibodies. However, one third of patients do not respond to treatment, and of those who do so at least another third will lose their response in the first year of treatment. It i...
  • curprev 16:1516:15, 12 October 2021DG Regio talk contribs 12,383 bytes +176 Changed label, description and/or aliases in en: translated_label
  • curprev 16:1516:15, 12 October 2021DG Regio talk contribs 12,207 bytes +2,188 Created claim: summary (P836): Inflammatory bowel disease is a significant public health problem due to its increasing incidence, appearance in the first decades of life, and chronic and sometimes invalidating condition. The key to the treatment of moderate to severe disease is anti-TNF monoclonal antibodies. However, one third of patients do not respond to treatment, and of those who do so at least another third will lose their response in the first year of treatment. It is...

10 October 2021

9 October 2021

8 October 2021